Table 1 Patient characteristics

From: A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer

Characteristic

Number of patients

%

Number of patients enrolled

42

 

 Evaluable for response

38

 

 Evaluable for safety

41

 

 Insufficient follow-up data

4

 

Age (years)

  

 Median

53.5

 

 Range

33–73

 

Sex

  

 Male

23

55

 Female

19

45

ECOG performance status

  

 0

2

5

 1

35

83

 2

5

12

Metastatic site

  

 Liver

15

36

 Lung

3

7

 Abdominal lymph node

28

67

 Neck node

10

24

 Peritoneum

5

12

 Bone

3

7

Number of metastatic sites

  

 1

15

36

 2

20

48

 ⩾3

7

17

Back to article page